Lodderomyces elongisporus: a bloodstream pathogen of greater clinical significance.

Related Articles

Lodderomyces elongisporus: a bloodstream pathogen of greater clinical significance.

New Microbes New Infect. 2018 Nov;26:20-24

Authors: Al-Obaid K, Ahmad S, Joseph L, Khan Z

Abstract
The true clinical significance of Lodderomyces elongisporus remains underestimated as a result of problems associated with its identification by the VITEK 2 yeast identification system. Here we describe a case of L. elongisporus primary progressive fungaemia in a woman with no known risk factors for invasive fungal infections. The isolate was identified by PCR sequencing of the internally transcribed spacer region of ribosomal DNA. Despite treatment with caspofungin, the patient died within 3 days of onset of fungaemia. Our literature review highlights this organism's emerging role as a bloodstream pathogen. A need for application of molecular methods for its accurate identification is emphasized.

PMID: 30245829 [PubMed]